Hamid Modarres Mousavi Behbahani

Hamid Modarres Mousavi Behbahani practices at Dignity Health - St. Mary Medical Center in Long Beach, California, part of CommonSpirit Health.

Hamid Modarres Mousavi Behbahani's NPI, 1285123778, was assigned on May 9, 2018. Hamid Modarres Mousavi Behbahani holds California license A174051.

Hamid Modarres Mousavi Behbahani's primary practice is Dignity Health - St. Mary Medical Center, at 1050 Linden Ave, Long Beach, CA 90813 in Los Angeles County. The practice phone is (562) 491-9000.

Hamid Modarres Mousavi Behbahani's primary practice is Dignity Health - St. Mary Medical Center in Long Beach, California, part of CommonSpirit Health. Hamid Modarres Mousavi Behbahani is also affiliated with Long Beach Medical Center. The medical group on file is Inpatient Specialist of California PC. Dmand AI also links Hamid Modarres Mousavi Behbahani to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hamid Modarres Mousavi Behbahani practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Hamid Modarres Mousavi Behbahani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Hamid Modarres Mousavi Behbahani is licensed in California.

CMS data shows 1,478 Medicare services from Hamid Modarres Mousavi Behbahani across 6 procedure codes in 2024, for 431 Medicare patients. Medicare paid $133,690 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 431 Medicare patients who saw Hamid Modarres Mousavi Behbahani in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 64% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hamid Modarres Mousavi Behbahani's median patient age at 60, with 53% women.

In 2024, Hamid Modarres Mousavi Behbahani wrote 258 Medicare Part D claims for 119 patients. 90% of them were for generic drugs. CMS names the drug for 103 of them, across 5 drugs with 11 or more claims each, at $419 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

Hamid Modarres Mousavi Behbahani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Hamid Modarres Mousavi Behbahani from 4 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $250.